PERRIGO
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company's test is based on database containing prostate cancer patients, as well as provides decision support for patients and… Read more
Market Cap & Net Worth: PERRIGO (PGO)
PERRIGO (F:PGO) has a market capitalization of $2.46 Million (€2.40 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #45673 globally and #7572 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PERRIGO's stock price €0.47 by its total outstanding shares 5148350 (5.15 Million).
PERRIGO Market Cap History: 2021 to 2024
PERRIGO's market capitalization history from 2021 to 2024. Data shows change from $678.10 Million to $2.46 Million (-21.22% CAGR).
PERRIGO Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PERRIGO's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.81x
PERRIGO's market cap is 1.81 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $139.42 Million | $10.00K | -$15.63 Million | 13940.81x | N/A |
| 2023 | $33.53 Million | $683.00K | -$29.09 Million | 49.09x | N/A |
| 2024 | $2.46 Million | $1.36 Million | -$41.44 Million | 1.81x | N/A |
Competitor Companies of PGO by Market Capitalization
Companies near PERRIGO in the global market cap rankings as of March 18, 2026.
Key companies related to PERRIGO by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
PERRIGO Historical Marketcap From 2021 to 2024
Between 2021 and today, PERRIGO's market cap moved from $678.10 Million to $ 2.46 Million, with a yearly change of -21.22%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | €2.46 Million | -92.66% |
| 2023 | €33.53 Million | -75.95% |
| 2022 | €139.42 Million | -79.44% |
| 2021 | €678.10 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 27th, 2025 the market cap of PERRIGO was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.46 Million USD |
| MoneyControl | $2.46 Million USD |
| MarketWatch | $2.46 Million USD |
| marketcap.company | $2.46 Million USD |
| Reuters | $2.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.